Diogo Nani

Mr. Diogo Nani

Laboratory of Molecular Biology, Instituto Jô Clemente, São Paulo, Brazil
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LALucas Alvizi
Lucas Alvizi
Diogo NaniDiogo Nani
Diogo Nani
LBLuciano Abreu Brito
Luciano Abreu Brito
GKGerson Shigeru Kobayashi
Gerson Shigeru Kobayashi
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
Roberto MayorRoberto Mayor
Roberto Mayor
Gene–environment interactions are believed to play a role in multifactorial phenotypes, although poorly described mechanistically. Cleft lip/palate (CLP), the most common craniofacial malformation, has been associated with both genetic and environmental factors, with little gene–environment interaction experimentally demonstrated. Here, we study CLP families harbouring CDH1/E-Cadherin variants with incomplete penetrance and we explore the association of pro-inflammatory conditions to CLP. By studying neural crest (NC) from mouse, Xenopus and humans, we show that CLP can be explained by a 2-hit model, where NC migration is impaired by a combination of genetic (CDH1 loss-of-function) and environmental (pro-inflammatory activation) factors, leading to CLP. Finally, using in vivo targeted methylation assays, we demonstrate that CDH1 hypermethylation is the major target of the pro-inflammatory response, and a direct regulator of E-cadherin levels and NC migration. These results unveil a gene–environment interaction during craniofacial development and provide a 2-hit mechanism to explain cleft lip/palate aetiology.

Verified
Journal Article
Open access
PDF file
Diogo NaniDiogo Nani
Diogo Nani
RMRodrigo Holanda Mendonça
Rodrigo Holanda Mendonça
FGFelipe Franco Franco da Graça
Felipe Franco Franco da Graça
VPVitoria Regia Pereira Pinheiro
Vitoria Regia Pereira Pinheiro
MCMirella Carneireiro
Mirella Carneireiro
VTVanessa Romanelli Tavares
Vanessa Romanelli Tavares
5q spinal muscular atrophy (5q-SMA) is a leading genetic cause of infant mortality. Presymptomatic intervention with disease-modifying therapies significantly improves motor outcomes, but effectiveness depends on early detection through newborn screening (NBS). Despite global 5q-SMA NBS expansion and recent Brazilian federal legislation, regional disparities and a lack of systematic monitoring hinder access to timely diagnosis and care. This study addresses these gaps by evaluating a statewide pilot program in São Paulo. We used multiplex real-time PCR to detect SMN1 exon 7 deletions in dried blood spots, confirming SMN1/2 copy numbers via MLPA in positive cases. Under real-world conditions, timeliness key performance indicators were evaluated to assess operational efficiency. 194,714 newborns were screened with 14 positive cases, yielding a prevalence of 1:13,908. First-tier results and treatment initiation occurred at a median of 10.8 and 28 days of life, respectively. Notably, 78.6% of patients had two SMN2 copies, of which approximately half were symptomatic by the first evaluation, highlighting the critical need for rapid screening to prevent irreversible motor decline. Screening achieved 100% specificity. This pilot demonstrates the feasibility of 5q-SMA NBS within the Brazilian public health system, providing essential evidence to overcome logistical and socioeconomic barriers and support nationwide expansion.

1 January 2021
Verified
Book Chapter
Closed access
PDF file
Diogo NaniDiogo Nani
Diogo Nani
GHGabriella Shih Ping Hsia
Gabriella Shih Ping Hsia
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
GKGerson Shigeru Kobayashi
Gerson Shigeru Kobayashi

28 September 2025 in bioRxiv
Verified
Preprint
Open access
Diogo NaniDiogo Nani
Diogo Nani
LALucas Alvizi
Lucas Alvizi
HBHeloisa Maria de Siqueira Bueno
Heloisa Maria de Siqueira Bueno
ELEllen Cristina Miranda Lacerda
Ellen Cristina Miranda Lacerda
CYChao Yun Irene Yan
Chao Yun Irene Yan
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
Cleft lip with or without palate (CLP) is a multifactorial trait associated with environmental exposures such as smoking, alcohol consumption, and pro-inflammatory conditions during early pregnancy, as well as with both common and rare genetic variants. Our group identified CDH1 loss-of-function variants segregating in families with CLP, with incomplete penetrance linked to promoter hypermethylation. Previously, we demonstrated that gene-environment interactions driven by pro-inflammatory factors can induce this methylation, downregulate E-cadherin expression, and impair neural crest migration, thereby contributing to the etiology of CLP. However, the embryonic consequences of the two-hit CLP model ( CDH1 haploinsufficiency combined with pro-inflammatory insult) have not yet been explored in mammals. Here, under single dose of floxed- Cdh1 , we investigated the pro-inflammatory response at the maternal-fetal interface, its impact on cytokine and Cdh1 expression along the anteroposterior axis, the associated epigenetic landscape in the embryonic head, and the effect on cranial structures. We found that pro-inflammatory activation differentially signals to the embryo between anterior and posterior regions, impairing Cdh1 /E-cadherin expression in NC cells of the head, accompanied by Cdh1 promoter hypermethylation and other differentially methylated genes involved in cell-junction maintenance. Our findings support a model in which maternal pro-inflammatory responses act as environmental factors that repress NC CDH1 expression through epigenetic mechanisms, contributing to CLP development by downregulating E-cadherin and potentially compromising overall epithelial integrity. Animal Ethics Committee (CEUA IB/USP) number approval: 394/2022